Outpatient oral anticancer agent utilization and costs in Manitoba from 2003 to 2016: a population-based study.

ABSTRACT:

Intervention

In April 2012, the Manitoba Home Cancer Drug Program (HCDP) was introduced to allow 100% coverage for eligible oral anticancer agents (OAA) and supportive medications for Manitobans with cancer requiring these therapies.

Research questions

What is the extent of use and cost of OAAs among outpatients in Manitoba from 2003/04 to 2015/16? Did the HCDP change OAA user and prescription patterns?

Methods

This was a retrospective, population-based study using administrative data to measure the prevalence of drug utilization over time and the impact of HCDP on OAA use and prescriptions using generalized linear models. Manitobans with cancer who filled an OAA or supportive medication covered by HCDP from 2003/04 to 2015/16 were included.

Results

This study

SUBMITTER: Leong C 

PROVIDER: S-EPMC8076393 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature